APO RESEARCH · REPORT
Gene Synthesis
Gene synthesis refers to chemically synthesizing a strand of DNA base-by-base. Unlike DNA replication that occurs in cells or by Polymerase Chain Reaction (PCR), gene synthesis does not require a template strand. Rather, gene synthesis involves the step-wise addition of nucleotides to a single-stranded molecule, which then serves as a template for creation of a complementary strand. Gene synthesis is the fundamental technology upon which the field of synthetic biology has been built.
Product & engineering
Understand the product.
Gene synthesis refers to chemically synthesizing a strand of DNA base-by-base. Unlike DNA replication that occurs in cells or by Polymerase Chain Reaction (PCR), gene synthesis does not require a template strand. Rather, gene synthesis involves the step-wise addition of nucleotides to a single-stranded molecule, which then serves as a template for creation of a complementary strand. Gene synthesis is the fundamental technology upon which the field of synthetic biology has been built.
Selected research
Industry Research
Gene Synthesis Industry Research Report 2026
Market perspective
Gene synthesis refers to chemically synthesizing a strand of DNA base-by-base. Unlike DNA replication that occurs in cells or by Polymerase Chain Reaction (PCR), gene synthesis does not require a template strand. Rather, gene synthesis involves the step-wise addition of nucleotides to a single-stranded molecule, which then serves as a template for creation of a complementary strand. Gene synthesis is the fundamental technology upon which the field of synthetic biology has been built.
Market competition is intense between top 5. Genescript, GeneArt (Thermofischer), IDT, DNA 2.0 (ATUM) and OriGene are the top 5 leaders of the industry, with about 76% market shares.
Report Scope
Read the full market overview
This report quantifies the global Gene Synthesis market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Gene Synthesis.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Gene Synthesis Market by Company
Genescript
GeneArt (Thermofischer)
IDT
DNA 2.0 (ATUM)
OriGene
BBI
Genewiz
Eurofins Genomics
Gene Oracle
SBS Genetech
Bio Basic
Gene Synthesis Segment by Type
Below 1000 bp
1001-3000 bp
3001-5000 bp
Above 5000 bp
Gene Synthesis Segment by Application
Commercial Research
Academic Research
Gene Synthesis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Synthesis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gene Synthesis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Synthesis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Gene Synthesis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Below 1000 bp
- 1001-3000 bp
- 3001-5000 bp
- Above 5000 bp
Applications
- Commercial Research
- Academic Research
Companies covered
- Genescript
- GeneArt (Thermofischer)
- IDT
- DNA 2.0 (ATUM)
- OriGene
- BBI
- Genewiz
- Eurofins Genomics
- Gene Oracle
- SBS Genetech
- Bio Basic
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Gene Synthesis by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Below 1000 bp
- 2.2.3 1001-3000 bp
- 2.2.4 3001-5000 bp
- 2.2.5 Above 5000 bp
- 2.3 Gene Synthesis by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Commercial Research
- 2.3.3 Academic Research
- 2.4 Assumptions and Limitations
3 Gene Synthesis Breakdown Data by Type
- 3.1 Global Gene Synthesis Historic Market Size by Type (2021-2026)
- 3.2 Global Gene Synthesis Forecasted Market Size by Type (2027-2032)
4 Gene Synthesis Breakdown Data by Application
- 4.1 Global Gene Synthesis Historic Market Size by Application (2021-2026)
- 4.2 Global Gene Synthesis Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Gene Synthesis Market Perspective (2021-2032)
- 5.2 Global Gene Synthesis Growth Trends by Region
- 5.2.1 Global Gene Synthesis Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Gene Synthesis Historic Market Size by Region (2021-2026)
- 5.2.3 Gene Synthesis Forecasted Market Size by Region (2027-2032)
- 5.3 Gene Synthesis Market Dynamics
- 5.3.1 Gene Synthesis Industry Trends
- 5.3.2 Gene Synthesis Market Drivers
- 5.3.3 Gene Synthesis Market Challenges
- 5.3.4 Gene Synthesis Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Gene Synthesis Players by Revenue
- 6.1.1 Global Top Gene Synthesis Players by Revenue (2021-2026)
- 6.1.2 Global Gene Synthesis Revenue Market Share by Players (2021-2026)
- 6.2 Global Gene Synthesis Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Gene Synthesis Head Office and Area Served
- 6.4 Global Gene Synthesis Players, Product Type & Application
- 6.5 Global Gene Synthesis Manufacturers Established Date
- 6.6 Global Gene Synthesis Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Gene Synthesis Market Size (2021-2032)
- 7.2 North America Gene Synthesis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Gene Synthesis Market Size by Country (2021-2026)
- 7.4 North America Gene Synthesis Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Gene Synthesis Market Size (2021-2032)
- 8.2 Europe Gene Synthesis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Gene Synthesis Market Size by Country (2021-2026)
- 8.4 Europe Gene Synthesis Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Gene Synthesis Market Size (2021-2032)
- 9.2 Asia-Pacific Gene Synthesis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Gene Synthesis Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Gene Synthesis Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Gene Synthesis Market Size (2021-2032)
- 10.2 South America Gene Synthesis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Gene Synthesis Market Size by Country (2021-2026)
- 10.4 South America Gene Synthesis Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Gene Synthesis Market Size (2021-2032)
- 11.2 Middle East & Africa Gene Synthesis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Gene Synthesis Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Gene Synthesis Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Genescript
- 12.1.1 Genescript Company Information
- 12.1.2 Genescript Business Overview
- 12.1.3 Genescript Revenue in Gene Synthesis Business (2021-2026)
- 12.1.4 Genescript Gene Synthesis Product Portfolio
- 12.1.5 Genescript Recent Developments
- 12.2 GeneArt (Thermofischer)
- 12.2.1 GeneArt (Thermofischer) Company Information
- 12.2.2 GeneArt (Thermofischer) Business Overview
- 12.2.3 GeneArt (Thermofischer) Revenue in Gene Synthesis Business (2021-2026)
- 12.2.4 GeneArt (Thermofischer) Gene Synthesis Product Portfolio
- 12.2.5 GeneArt (Thermofischer) Recent Developments
- 12.3 IDT
- 12.3.1 IDT Company Information
- 12.3.2 IDT Business Overview
- 12.3.3 IDT Revenue in Gene Synthesis Business (2021-2026)
- 12.3.4 IDT Gene Synthesis Product Portfolio
- 12.3.5 IDT Recent Developments
- 12.4 DNA 2.0 (ATUM)
- 12.4.1 DNA 2.0 (ATUM) Company Information
- 12.4.2 DNA 2.0 (ATUM) Business Overview
- 12.4.3 DNA 2.0 (ATUM) Revenue in Gene Synthesis Business (2021-2026)
- 12.4.4 DNA 2.0 (ATUM) Gene Synthesis Product Portfolio
- 12.4.5 DNA 2.0 (ATUM) Recent Developments
- 12.5 OriGene
- 12.5.1 OriGene Company Information
- 12.5.2 OriGene Business Overview
- 12.5.3 OriGene Revenue in Gene Synthesis Business (2021-2026)
- 12.5.4 OriGene Gene Synthesis Product Portfolio
- 12.5.5 OriGene Recent Developments
- 12.6 BBI
- 12.6.1 BBI Company Information
- 12.6.2 BBI Business Overview
- 12.6.3 BBI Revenue in Gene Synthesis Business (2021-2026)
- 12.6.4 BBI Gene Synthesis Product Portfolio
- 12.6.5 BBI Recent Developments
- 12.7 Genewiz
- 12.7.1 Genewiz Company Information
- 12.7.2 Genewiz Business Overview
- 12.7.3 Genewiz Revenue in Gene Synthesis Business (2021-2026)
- 12.7.4 Genewiz Gene Synthesis Product Portfolio
- 12.7.5 Genewiz Recent Developments
- 12.8 Eurofins Genomics
- 12.8.1 Eurofins Genomics Company Information
- 12.8.2 Eurofins Genomics Business Overview
- 12.8.3 Eurofins Genomics Revenue in Gene Synthesis Business (2021-2026)
- 12.8.4 Eurofins Genomics Gene Synthesis Product Portfolio
- 12.8.5 Eurofins Genomics Recent Developments
- 12.9 Gene Oracle
- 12.9.1 Gene Oracle Company Information
- 12.9.2 Gene Oracle Business Overview
- 12.9.3 Gene Oracle Revenue in Gene Synthesis Business (2021-2026)
- 12.9.4 Gene Oracle Gene Synthesis Product Portfolio
- 12.9.5 Gene Oracle Recent Developments
- 12.10 SBS Genetech
- 12.10.1 SBS Genetech Company Information
- 12.10.2 SBS Genetech Business Overview
- 12.10.3 SBS Genetech Revenue in Gene Synthesis Business (2021-2026)
- 12.10.4 SBS Genetech Gene Synthesis Product Portfolio
- 12.10.5 SBS Genetech Recent Developments
- 12.11 Bio Basic
- 12.11.1 Bio Basic Company Information
- 12.11.2 Bio Basic Business Overview
- 12.11.3 Bio Basic Revenue in Gene Synthesis Business (2021-2026)
- 12.11.4 Bio Basic Gene Synthesis Product Portfolio
- 12.11.5 Bio Basic Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst